Search Results

SFDA Closed Out Five Violating Medical Products Stores in Dammam Warnings

Safety Signal of Atorvastatin and the Risk of Anxiety Safety Alert

International for Information Technology service providing facilities

Guideline for Testing of Residual Formaldehyde Regulations

SFDA" warns about an error in "Easy Vision contact Lenses" size (-6.5) Warnings

Saudi FDA and OIC Organize Workshop on Strengthening Regulatory Systems in Collaboration with WHO News

SFDA Recommended Protective Actions to Patients of Implanted KAMPRA™ Lense Warnings

A Phase II, Multi-centre Open Label Study to Assess the Efficacy and Safety of Oral Apabetalone with Background Dapagliflozin in Subjects with Long -COVID-19 (Post-COVID-19 Conditions) and Type 2 Diabetes Mellitus (T2DM) Drug Clinical Trial

A randomised, double-blind, placebo-controlled, multicentre, Phase III trial evaluating long-term efficacy and safety of survodutide weekly injections in adult participants with non-cirrhotic non-alcoholic steatohepatitis/metabolic associated steatohepatitis (NASH/MASH) and (F2) - (F3) stage of liver fibrosis Drug Clinical Trial

EASi-HF reduced – A Phase III double-blind, randomised, parallel-group superiority trial to evaluate efficacy and safety of the combined use of oral vicadrostat (BI 690517) and empagliflozin compared with placebo and empagliflozin in participants with symptomatic chronic heart failure (HF: NYHA II-IV) and left ventricular ejection fraction (LVEF) < 40% Drug Clinical Trial

Displaying 561 - 570 of 7889